ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

Contracts Awarded For $30 Million Heavy Smokers Clinical Trials

October 10, 1986

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991

In Brief: CT Scanning Of The Brain Subject Of Consensus Development Conference; CCI Plans Congress Events

July 10, 1981

Field Studies Chief Leave For Job with Upton; Sibal Named DCCP Acting Deputy

October 27, 1978